00874 白雲山
公司資料 - 損益表
廣州白雲山醫藥集團股份有限公司 股票編號: 00874
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED 集團網址: http://www.gybys.com.cn
2023/12 - 末期
人民幣(K¥)
變動 2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)
營業額 / 收益75,515,4046.678%70,788,15569,014,05261,673,70264,951,778
銷售成本------------
毛利------------
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值(48,028)-15.326%(56,721)75,208(147,971)(89,896)
出售項目溢利 / (虧損)12,0271643.510%6906952,9541,274
其他非經營項目------------
分佔聯營公司及共同控制公司業績107,888-21.012%136,588122,950355,658144,486
除稅前溢利 / (虧損)5,110,4981.334%5,043,2444,723,0713,739,0824,128,533
稅項(851,170)7.760%(789,874)(754,085)(647,454)(687,246)
已終止經營業務溢利 / (虧損)------------
非控股權益(203,649)-29.004%(286,848)(249,108)(176,383)(252,403)
其他項目------------
股東應佔溢利 / (虧損)4,055,6792.248%3,966,5223,719,8782,915,2453,188,885
 
淨財務支出 / (收入)(19,561)-87.959%(162,456)(133,010)5,152117,117
折舊及攤銷985,32024.150%793,656720,522679,551625,783
董事酬金5,13392.788%2,6634,4664,3613,838
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)249.500--244.000228.800179.300196.100
每股派息 (仙)74.900--73.20068.70053.80058.900
派息比率 (%)30.020%--30.000%30.026%30.006%30.036%
每股現金流 ($)2.524--4.3053.4900.3603.089
每股帳面資產淨值 ($)21.478--19.72317.87616.08114.876
 

Copyright © 2024 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.